Phase II Study of Oral Panobinostat in Adult Patients With Relapsed / Refractory Classical Hodgkin's Lymphoma

Phase II Study of Oral Panobinostat in Adult Patients With Relapsed / Refractory Classical Hodgkin's Lymphoma

Sponsor(s)

Novartis Pharmaceuticals Corporation

Principal Investigator(s)Jonathan L Kaufman, MD
Dates6/15/2008 - 1/30/2012